Screener
Beta Bionics
BBNXBeta Bionics is a commercial-stage medical device company that develops and commercializes automated insulin delivery systems for people with diabetes.
Earnings
Next report
Oct 27, 2026 (in 2 months)Revenue estimate$35.0M
EPS estimate-$0.55
Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
Beta Bionics is a commercial-stage medical device company that develops and commercializes automated insulin delivery systems for people with diabetes. Its core value proposition is the iLet Bionic Pancreas, a fully closed-loop system that utilizes adaptive algorithms to autonomously determine and deliver all insulin doses, significantly reducing the cognitive and manual burden of disease management.
Competitive position
Beta Bionics is a pioneer in the 'true fully closed-loop' category, offering the only FDA-cleared device that eliminates carbohydrate counting and manual bolus calculations.
GeographiesUnited States
Customer segmentsPatients, Healthcare Providers, Insurance Payors
Business modelManufacturing, Direct-to-Consumer, Recurring Revenue
SuppliersComponent and subassembly suppliers, Continuous Glucose Monitor (CGM) manufacturers, Insulin manufacturers
CustomersType 1 diabetes patients, Endocrinology clinics, Independent medical distributors, Pharmacy benefit managers
CountryUnited States of America
Listed2025
CEOSean T. Saint
SectorHealthcare
IndustryMedical - Equipment & Services
Websitebetabionics.com
FilingsSEC EDGAR
FAQ
- What is Beta Bionics's market cap?
- Beta Bionics (BBNX) has a market capitalization of $715.3M and trades on NASDAQ.
- What is Beta Bionics's revenue and profitability?
- Beta Bionics generated $119.0M in trailing twelve-month revenue with a net loss of $73.0M, representing a net margin of -61.3%. Gross margin stands at 58.3%, with free cash flow of -$61.4M. These figures are based on the Q2 2026 filing.
- Who are Beta Bionics's competitors?
- Beta Bionics's key competitors include Tandem Diabetes Care, Insulet, Medtronic, and others. These companies compete in similar markets and product categories.
- Who does Beta Bionics partner with?
- Beta Bionics's notable partners include DexCom, Abbott Laboratories, Xeris Pharmaceuticals, and others.
- Where is Beta Bionics headquartered?
- Beta Bionics is headquartered in United States of America. It has been publicly traded since 2025.
